{"disease":{"id":"ascariasis","name":"Ascariasis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"thiabendazole","indication_name":"Ascariasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bovizole","generic_name":"THIABENDAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 1A2","drug_class":"Anthelmintic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"piperazine","indication_name":"Ascariasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Antiren","generic_name":"PIPERAZINE","company_name":"Bluline","drug_phase":"marketed","molecular_target":"","drug_class":"piperazine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"mebendazole","indication_name":"Ascariasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vermox","generic_name":"MEBENDAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor receptor 2","drug_class":"Anthelmintic [EPC]","quality_score":10,"revenue":null,"mechanism":"Vermox works by interfering with the parasite's ability to absorb glucose, ultimately leading to its death."},{"drug_id":"levamisole","indication_name":"Ascariasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levamisol","generic_name":"LEVAMISOLE","company_name":"","drug_phase":"marketed","molecular_target":"Alkaline phosphatase, tissue-nonspecific isozyme","drug_class":"levamisole","quality_score":30,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04700423","title":"Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":536,"lead_sponsor_name":"Jennifer Keiser","has_results":true},{"nct_id":"NCT06184399","title":"Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Jennifer Keiser","has_results":true},{"nct_id":"NCT04726969","title":"Efficacy and Safety of MOX/ALB Co-administration","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":255,"lead_sponsor_name":"Jennifer Keiser","has_results":true},{"nct_id":"NCT06188715","title":"Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Jennifer Keiser","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}